| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $343.1M | +1.5% | +0.6% |
| Cost of Revenue | $247.0M | — | +1.5% |
| Gross Profit | $96.1M | -0.6% | -1.7% |
| R&D Expense | $18.7M | — | -5.6% |
| SG&A Expense | $53.1M | — | -12.3% |
| Operating Income | $19.6M | +57.3% | +12.8% |
| Pre-tax Income | $7.9M | — | -36.2% |
| Income Tax | $1.8M | — | -71.6% |
| Net Income | $5.3M | — | +1.0% |
| EPS (Basic) | $0.04 | — | -60.0% |
| EPS (Diluted) | $0.04 | — | -60.0% |
| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $461.5M | +1.7% | +24.6% |
| Short-term Investments | $0 | — | -100.0% |
| Inventory | $213.2M | -16.4% | -13.7% |
| Current Assets | $1.07B | +0.3% | +7.2% |
| Total Assets | $1.60B | -1.2% | +1.0% |
| Current Liabilities | $458.1M | -3.3% |
| Line Item | 2025-11-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $31.1M | — | +124.7% |
| Capital Expenditures | $2.9M | — | +55.4% |
| Investing Cash Flow | -$3.4M | — | +82.2% |
| Financing Cash Flow | -$20.0M | — | -157.5% |
| Free Cash Flow | $28.2M | — | +135.4% |
| +7.3% |
| Long-term Debt | $462.3M | +0.1% | -29.7% |
| Total Liabilities | $993.7M | -1.5% | -15.4% |
| Stockholders' Equity | $389.7M | -1.2% | -2.7% |